Eli Lilly and Company
Eli Lilly and Company (LLY.DE) Stock Competitors & Peer Comparison
See (LLY.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LLY.DE | €772.20 | -2.99% | 749.1B | 40.31 | €19.67 | +0.68% |
| JNJ.DE | €201.50 | -0.07% | 491.6B | 21.58 | €9.46 | +2.18% |
| 4AB.DE | €175.40 | +0.72% | 312.5B | 87.45 | €2.02 | +3.24% |
| 6MK.DE | €99.45 | -2.58% | 251.9B | 16.33 | €6.24 | +2.79% |
| ZEG.DE | €160.70 | +0.59% | 249.2B | 28.75 | €5.59 | +1.69% |
| AMG.DE | €293.20 | -1.23% | 160.1B | 24.31 | €12.22 | +2.78% |
| GIS.DE | €117.60 | +0.29% | 147.8B | 20.53 | €5.80 | +2.30% |
| PFE.F | €23.12 | +0.57% | 131.5B | 19.93 | €1.16 | +6.36% |
| PFE.DE | €22.96 | +0.15% | 131.5B | 19.93 | €1.16 | +6.35% |
| BRM.DE | €48.86 | -1.11% | 101B | 16.76 | €2.96 | +4.32% |
Stock Comparison
LLY.DE vs JNJ.DE Comparison April 2026
LLY.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LLY.DE stands at 749.1B. In comparison, JNJ.DE has a market cap of 491.6B. Regarding current trading prices, LLY.DE is priced at €772.20, while JNJ.DE trades at €201.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LLY.DE currently has a P/E ratio of 40.31, whereas JNJ.DE's P/E ratio is 21.58. In terms of profitability, LLY.DE's ROE is +0.98%, compared to JNJ.DE's ROE of +0.34%. Regarding short-term risk, LLY.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for LLY.DE.Check JNJ.DE's competition here